Our present study identifies an important role for GLP-1R in diabetes treatment, highlights the potential of natural plant-derived substances in the treatment of diabetic cognitive impairment, and provides new ideas for the future development of drugs to treat diabetic cognitive dysfunction. The gene discussed is GLP1R; the disease is diabetes mellitus.